Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | 0.064 | 0.04 |
mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | 0.062 | 0.04 |
mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.07 | 0.05 |
mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.088 | 0.05 |
mRNA | GW843682X | GDSC1000 | pan-cancer | AAC | -0.1 | 0.05 |
mRNA | tubastatin A | CTRPv2 | pan-cancer | AAC | -0.098 | 0.05 |
mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | 0.071 | 0.05 |
mRNA | indisulam | CTRPv2 | pan-cancer | AAC | 0.06 | 0.06 |
mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | 0.068 | 0.06 |
mRNA | VX-680 | GDSC1000 | pan-cancer | AAC | -0.099 | 0.06 |